These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8736619)

  • 1. Ebrotidine.
    Patel SS; Wilde MI
    Drugs; 1996 Jun; 51(6):974-80; discussion 981. PubMed ID: 8736619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebrotidine--a nostrum for ulcer.
    Grover JK; Rathi SS; Vats V
    Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroprotective and ulcer-healing activities of a new H2-receptor antagonist: ebrotidine.
    Brzozowski T; Majka J; Konturek SJ
    Digestion; 1992; 51(1):27-36. PubMed ID: 1353465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ebrotidine].
    Elizalde JI
    Gastroenterol Hepatol; 1997 Feb; 20(2):65-7. PubMed ID: 9072206
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
    Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroprotective and antisecretory effects of ebrotidine.
    Konturek SJ; Maczka J; Kaminski K; Sito E; Torres J; Oleksy J
    Scand J Gastroenterol; 1992 Jun; 27(6):438-42. PubMed ID: 1352908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement in the protective qualities of gastric mucus by ebrotidine during duodenal ulcer healing.
    Slomiany BL; Piotrowski J; Majka J; Czajkowski A; Slomiany A; Gabryelewicz A
    Gen Pharmacol; 1995 Sep; 26(5):1039-44. PubMed ID: 7557247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
    Piotrowski J; Majka J; Piotrowski E; Murty VL; Gabryelewicz A; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1994 Nov; 34(5):875-81. PubMed ID: 7535617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine.
    Arroyo MT; Lanas A; Sáinz R
    Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):313-8. PubMed ID: 10750652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
    Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Helicobacter pylori urease activity by ebrotidine.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1995 Oct; 37(2):247-53. PubMed ID: 8673007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
    Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication.
    Slomiany BL; Piotrowski J; Slomiany A; Konturek JW; Domschke WW
    Gen Pharmacol; 1998 Aug; 31(2):227-31. PubMed ID: 9688464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer.
    Gabryelewicz A; Konturek SJ; Butruk E; Dzieniszewski J; Marlicz K; Nowak A; Torres J; Marquez M; Ortiz JA
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):361-6. PubMed ID: 7600143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
    Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
    J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease.
    Sito E; Thor PJ; M[aczka M; Lorens K; Konturek SJ; Maj A
    J Physiol Pharmacol; 1993 Sep; 44(3):259-72. PubMed ID: 8241527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ebrotidine on aspirin-induced gastric mucosal damage and blood flow in humans.
    Konturek SJ; Kwiecien N; Sito E; Obtulowicz W; Kaminski K; Oleksy J
    Scand J Gastroenterol; 1993 Dec; 28(12):1047-50. PubMed ID: 7905660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
    Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.